Skip to main content
. 2016 Jun 30;7(31):49299–49309. doi: 10.18632/oncotarget.10335

Figure 3. The shape of association between HBV DNA level and HCC risk, with restricted cubic splines in random-effects dose-response model.

Figure 3

The solid line and the short dash line represent the estimated relative risks and corresponding 95% CIs, respectively.